Development and optimization of a dual-photoinitiator, emulsion-based technique for rapid generation of cell-laden hydrogel microspheres

Acta Biomaterialia

Volumn 7, Issue 9, 2011, Pages 3267-3276

  Franco, C L ^a   Price, J ^b   West, J L ^a  

^a Rice University   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cell therapy; Hydrogel; Microcarrier; Microencapsulation; Poly(ethylene glycol)

Indexed keywords

CELL CULTURE; CELL ENGINEERING; DISEASE CONTROL; EMULSIFICATION; ETHYLENE GLYCOL; GELATION; LABORATORIES; MICROENCAPSULATION; MICROSPHERES; ORGANIC SOLVENTS; POLYETHYLENE GLYCOLS; POLYOLS; SCAFFOLDS (BIOLOGY); STEM CELLS;

CELL THERAPY; CELL-BASED THERAPY; CLINICAL TRIAL; DIACRYLATES; HYDROGEL MICROSPHERES; MICROCARRIERS; OPTIMISATIONS; PHOTOINITIATORS; PRECURSOR SOLUTIONS; RAPID GENERATIONS;

HYDROGELS;

MICROSPHERE; MINERAL OIL; PHOTOINITIATOR; POLY(ETHYLENE GLYCOL)DIACRYLATE; POLYMER; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CELL CULTURE; CELL ENCAPSULATION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; EMULSION; GELATION; HUMAN; HUMAN CELL; HYDROGEL; NEURAL STEM CELL; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SYNTHESIS;

EID: 79961015324     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2011.06.011     Document Type: Article

References (70)

1. Bottino R, Lemarchand P, Trucco M, Giannoukakis N. Gene- and cell-based therapeutics for type I diabetes mellitus. Gene Ther 2003;10(10):875-89. (Pubitemid 36665298)
2. Wright JR, Pohajdak B. Cell therapy for diabetes using piscine islet tissue. Cell Transplant 2001;10(2):125-43. (Pubitemid 32381691)
3. Sambanis A. Engineering challenges in the development of an encapsulated cell system for treatment of type 1 diabetes. Diabetes Technol Ther 2000;2(1): 81-9. (Pubitemid 30256426)
4. Efrat S. Cell therapy approaches for the treatment of diabetes. Curr Opin Invest Drugs (2000) 2001;2(5):639-42.
5. de Vos P, Hamel AF, Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 2002;45(2): 159-73. (Pubitemid 34208378)
6. Hussain MA, Theise ND. Stem-cell therapy for diabetes mellitus. Lancet 2004;364(9429):203-5.
7. Sambanis A. Encapsulated islets in diabetes treatment. Diabetes Technol Ther 2003;5(4):665-8. (Pubitemid 36999279)
8. Opara EC, Mirmalek-Sani S-H, Khanna O, Moya ML, Brey EM. Design of a bioartificial pancreas(+). J Invest Med: Official Publ Am Fed Clin Res 2010;58(7):831-7.
9. Robertson RP. Update on transplanting beta cells for reversing type 1 diabetes. Endocrinol Metab Clin North Am 2010;39(3):655-67.
10. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004;95(1):9-20. (Pubitemid 38931831)
11. Satija NK, Singh VK, Verma YK, Gupta P, Sharma S, Afrin F, et al. Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med n.d.;13(11-12):4385-4402.
12. Schuleri KH, Boyle AJ, Hare JM. Mesenchymal stem cells for cardiac regenerative therapy. Handb Exp Pharmacol 2007;180(180):195-218.
13. Singla DK. Stem cells in the infarcted heart. J Cardiovas Translational Res 2010;3(1):73-8.
14. Picinich SC, Mishra PJ, Mishra PJ, Glod J, Banerjee D. The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy. Expert Opin Biol Ther 2007;7(7):965-73. (Pubitemid 47204355)
15. Burns TC, Verfaillie CM, Low WC. Stem cells for ischemic brain injury: a critical review. J Comp Neurol 2009;515(1):125-44.
16. Abe K. Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury. J Cerebral Blood Flow Metab: Official J Int Soc Cerebral Blood Flow Metab 2000;20(10):1393-408.
17. Miljan EA, Sinden JD. Stem cell treatment of ischemic brain injury. Curr Opin Mol Ther 2009;11(4):394-403.
18. Pollock K, Stroemer P, Patel S, Stevanato L, Hope A, Miljan E, et al. A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp Neurol 2006;199(1):143-55. (Pubitemid 43959830)
19. Hicks A, Jolkkonen J. Challenges and possibilities of intravascular cell therapy in stroke. Acta Neurobiol Exp 2009;69(1):1-11.
20. Park KI, Teng YD, Snyder EY. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol 2002;20(11):1111-7. (Pubitemid 35285439)
21. Wong AM, Hodges H, Horsburgh K. Neural stem cell grafts reduce the extent of neuronal damage in a mouse model of global ischaemia. Brain Res 2005;1063(2):140-50. (Pubitemid 41741025)
22. Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature 2006;441(7097):1094-6. (Pubitemid 43990722)
23. Kelly S, Bliss TM, Shah AK, Sun GH, Ma M, Foo WC, et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci USA 2004;101(32):11839-44. (Pubitemid 39095381)
24. Nyolczas N, Gyöngyösi M, Beran G, Dettke M, Graf S, Sochor H, et al. Design and rationale for the myocardial stem cell administration after acute myocardial infarction (MYSTAR) study: a multicenter, prospective, randomized, singleblind trial comparing early and late intracoronary or combined (percutaneous intramyocardial). Am Heart J 2007;153(2):212-7.
25. Kondziolka D, Wechsler L, Achim C. Neural transplantation for stroke. J Clin Neurol 2002;9(3):225-30.
26. Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, Strazzer S, et al. Stem cell therapy in stroke. Cell Mol Life Sci: CMLS 2009;66(5):757-72.
27. Nystul TG, Spradling AC. Breaking out of the mold: diversity within adult stem cells and their niches. Curr Opin Genet Dev 2006;16(5):463-8. (Pubitemid 44345200)
28. Li L, Xie T. Stem cell niche: structure and function. Annu Rev Cell Dev Biol 2005;21:605-31. (Pubitemid 41740648)
29. Fuchs E, Tumbar T, Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 2004;116(6):769-78. (Pubitemid 38410723)
30. Watt FM. Out of Eden: stem cells and their niches. Science 2000;287(5457): 1427-30. (Pubitemid 30127126)
31. Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche. Nature 2001;414(6859):98-104. (Pubitemid 33041633)
32. Nicodemus GD, Bryant SJ. Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng Part B Rev 2008;14(2):149-65. (Pubitemid 351839212)
33. Orive G, Hernández RM, Rodríguez Gascón A, Calafiore R, Chang TMS, de Vos P, et al. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol 2004;22(2):87-92. (Pubitemid 38130176)
34. Murua A, Portero A, Orive G, Hernández RM, de Castro M, Pedraz JL. CastroMde, Pedraz JL. Cell microencapsulation technology: towards clinical application. J Controlled Release: Official J Controlled Release Soc 2008;132(2):76-83.
35. Jen AC, Wake MC, Mikos AG. Review: hydrogels for cell immobilization. Biotechnol Bioeng 1996;50(4):357-64. (Pubitemid 26126669)
36. Orive G, Hernández RM, Gascón AR, Calafiore R, Chang TMS, de Vos P, et al. Cell encapsulation: promise and progress. Nat Med 2003;9(1):104-7. (Pubitemid 36098269)
37. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science (New York, NY) 1980;210(4472):908-10. (Pubitemid 11169847)
38. Smidsrød O, Skjåk-Braek G. Alginate as immobilization matrix for cells. Trends Biotechnol 1990;8(3):71-8.
39. Martinsen A, Skjåk-Braek G, Smidsrød O. Alginate as immobilization material: I. Correlation between chemical and physical properties of alginate gel beads. Biotechnol Bioeng 1989;33(1):79-89.
40. Haque T, Chen H, Ouyang W, Martoni C, Lawuyi B, Urbanska AM, et al. Superior cell delivery features of poly(ethylene glycol) incorporated alginate, chitosan, and poly-L-lysine microcapsules. Mol Pharm 2004;2(1):29-36. (Pubitemid 40314727)
41. Hunt NC, Grover LM. Cell encapsulation using biopolymer gels for regenerative medicine. Biotechnol Lett 2010;32(6):733-42.
42. Köster S, Angilè FE, Duan H, Agresti JJ, Wintner A, Schmitz C, et al. Drop-based microfluidic devices for encapsulation of single cells. Lab Chip 2008;8(7): 1110-5. (Pubitemid 351904829)
43. Tumarkin E, Kumacheva E. Microfluidic generation of microgels from synthetic and natural polymers. Chem Soc Rev 2009;38(8):2161-8.
44. DeLong SA, Gobin AS, West JL. Covalent immobilization of RGDS on hydrogel surfaces to direct cell alignment and migration. J Controlled Release: Official J Controlled Release Soc 2005;109(1-3):139-48. (Pubitemid 41737260)
45. Hern DL, Hubbell JA. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J Biomed Mater Res 1998;39(2): 266-76. (Pubitemid 28060360)
46. Hubbell JA. Biomaterials in tissue engineering. Bio/Technology 1995;13(6):565-76.
47. Burdick JA, Anseth KS. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials 2002;23(22):4315-23.
48. Gobin AS, West JL. Effects of epidermal growth factor on fibroblast migration through biomimetic hydrogels. Biotechnol Prog 2003;19(6):1781-5. (Pubitemid 37529215)
49. Gobin AS, West JL. Cell migration through defined, synthetic ECM analogs. FASEB J: Official Publ Fed Am Soc Exp Biol 2002;16(7):751-3.
50. Mann BK, Gobin AS, Tsai AT, Schmedlen RH, West JL. Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: synthetic ECM analogs for tissue engineering. Biomaterials 2001;22(22):3045-51. (Pubitemid 32768712)
51. Moon JJ, Saik JE, Poché RA, Leslie-Barbick JE, Lee S-H, Smith AA, et al. Biomimetic hydrogels with pro-angiogenic properties. Biomaterials 2010;31(14):3840-7.
52. West JL, Hubbell JA. Polymeric biomaterials with degradation sites for proteases involved in cell migration. Macromolecules 1999;32(1):241-4.
53. Leslie-Barbick JE, Moon JJ, West JL. Covalently-immobilized vascular endothelial growth factor promotes endothelial cell tubulogenesis in poly(ethylene glycol) diacrylate hydrogels. J Biomater Sci Polym Ed 2009;20(12):1763-79.
54. Lutolf MP, Lauer-Fields JL, Schmoekel HG, Metters AT, Weber FE, Fields GB, et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci USA 2003;100(9):5413-8. (Pubitemid 36542719)
55. Yeh J, Ling Y, Karp JM, Gantz J, Chandawarkar A, Eng G, et al. Micromolding of shape-controlled, harvestable cell-laden hydrogels. Biomaterials 2006;27(31): 5391-8. (Pubitemid 44093713)
56. Michaels JD, Papoutsakis ET. Polyvinyl alcohol and polyethylene glycol as protectants against fluid-mechanical injury of freely-suspended animal cells (CRL 8018). J Biotechnol 1991;19(2-3):241-57.
57. Gray JA, Hodges H, Sinden J. Prospects for the clinical application of neural transplantation with the use of conditionally immortalized neuroepithelial stem cells. Philos Trans R Soc London Series B, Biol Sci 1999;354(1388): 1407-21. (Pubitemid 29423084)
58. Sinden JD, Rashid-Doubell F, Kershaw TR, Nelson A, Chadwick A, Jat PS, et al. Recovery of spatial learning by grafts of a conditionally immortalized hippocampal neuroepithelial cell line into the ischaemia-lesioned hippocampus. Neuroscience 1997;81(3):599-608. (Pubitemid 27402509)
59. Tryggvason K, Huhtala P, Tuuttila A, Chow L, Keski-Oja J, Lohi J. Structure and expression of type IV collagenase genes. Cell Differ Dev: Official J Int Soc Dev Biologists 1990;32(3):307-12.
60. Bryant SJ, Nuttelman CR, Anseth KS. Cytocompatibility of UV and visible light photoinitiating systems on cultured NIH/3T3 fibroblasts in vitro. J Biomater Sci Polym Ed 2000;11(5):439-57. (Pubitemid 30420957)
61. Williams CG, Malik AN, Kim TK, Manson PN, Elisseeff JH. Variable cytocompatibility of six cell lines with photoinitiators used for polymerizing hydrogels and cell encapsulation. Biomaterials 2005;26(11):1211-8. (Pubitemid 39314494)
62. Obara K, Ishihara M, Ishizuka T, Fujita M, Ozeki Y, Maehara T, et al. Photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 stimulates wound healing in healing-impaired db/db mice. Biomaterials 2003;24(20):3437-44. (Pubitemid 36703118)
63. Ishihara M, Obara K, Ishizuka T, Fujita M, Sato M, Masuoka K, et al. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J Biomater Sci Part A 2003;64(3):551-9. (Pubitemid 37522496)
64. Li Q, Ford MC, Lavik EB, Madri JA. Modeling the neurovascular niche: VEGF-and BDNF-mediated cross-talk between neural stem cells and endothelial cells: an in vitro study. J Neurosci Res 2006;84(8):1656-68. (Pubitemid 44892600)
65. Palmer TD, Willhoite AR, Gage FH. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 2000;425(4):479-94.
66. Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, Abramova N, et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science (New York, NY) 2004;304(5675):1338-40. (Pubitemid 38697433)
67. Teng H, Zhang ZG, Wang L, Zhang RL, Zhang L, Morris D, et al. Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J Cerebral Blood Flow Metabol: Official J Int Soc Cerebral Blood Flow Metabol 2008;28(4):764-71. (Pubitemid 351432788)
68. Dikovsky D, Bianco-Peled H, Seliktar D. Defining the role of matrix compliance and proteolysis in three-dimensional cell spreading and remodeling. Biophys J 2008;94(7):2914-25.
69. Raeber GP, Lutolf MP, Hubbell JA. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J 2005;89(2):1374-88. (Pubitemid 41099019)
70. Montesano R, Pepper MS, Möhle-Steinlein U, Risau W, Wagner EF, Orci L. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 1990;62(3):435-45.